Zafgen says obesity drug succeeds in late-stage study

(Reuters) - Zafgen Inc said its experimental obesity drug, on complete clinical hold since last month after the death of two patients, met its main goals in a late-stage study in patients with a rare genetic eating disorder.

http://ift.tt/1Rzv7PC

from Reuters: Health News
via animenewspro